Skip to main content
Premium Trial:

Request an Annual Quote

China FDA Grants Expedited Review to MammaTyper Breast Cancer Dx

NEW YORK (GenomeWeb) – Germany-based BioNTech Diagnostics and Shuwen Biotech, its partner in China, announced that their MammaTyper real-time PCR breast cancer stratification kit has been granted an expedited review for regulatory approval by the China Food and Drug Administration (CFDA).

The agency will review the diagnostic under a special process designed to expedite the approval of innovative products, the companies said.

MammaTyper, which is also CE-IVD marked for use in Europe, is a molecular diagnostic test for breast cancer stratification with formalin-fixed paraffin-embedded tumor tissue samples. The test measures four genes in breast cancer tissue via real-time qPCR in order to stratify tumor samples into four subtypes: luminal A-like, luminal B-like/HER2 negative, luminal B-like/HER2 positive, HER2 positive/non-luminal, and triple-negative/ductal. The goal is to improve the accuracy of diagnosis and inform treatment decisions, BioNTech said.

"We are very pleased that the CFDA has recognized the innovative and significant clinical value of MammaTyper," said Shuwen Chairman and CEO Jay Zhang in a statement. "We will work closely with the CFDA towards an expedited approval to allow Chinese breast cancer patients to have full access to the clinical benefit of MammaTyper."

BioNTech and Shuwen signed a deal to commercialize MammaTyper in China in early December 2015. Later that month, the company told GenomeWeb that it was looking to globally commercialize the diagnostic, and was looking for a US partner to usher the test through US Food and Drug Administration approval.

The Scan

Germline-Targeting HIV Vaccine Shows Promise in Phase I Trial

A National Institutes of Health-led team reports in Science that a broadly neutralizing antibody HIV vaccine induced bnAb precursors in 97 percent of those given the vaccine.

Study Uncovers Genetic Mutation in Childhood Glaucoma

A study in the Journal of Clinical Investigation ties a heterozygous missense variant in thrombospondin 1 to childhood glaucoma.

Gene Co-Expression Database for Humans, Model Organisms Gets Update

GeneFriends has been updated to include gene and transcript co-expression networks based on RNA-seq data from 46,475 human and 34,322 mouse samples, a new paper in Nucleic Acids Research says.

New Study Investigates Genomics of Fanconi Anemia Repair Pathway in Cancer

A Rockefeller University team reports in Nature that FA repair deficiency leads to structural variants that can contribute to genomic instability.